Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment

Clinical Hemorheology and Microcirculation

Volumn 21, Issue 3-4, 1999, Pages 209-216

  Toth, K ^a   Kesmarky, G ^a   Vekasi, J ^a   Nemes, J ^a   Czopf, L ^a   Kapronczay, P ^a   Halmosi, R ^a   Papp, E ^a   Juricskay, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Blood rheology; Cardiovascular diseases; Drug treatment; Hypertension; Hypertensive retinopathy

Indexed keywords

ALPHA 1 ANTITRYPSIN; DOXAZOSIN; FIBRINOGEN;

ADULT; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INDEX; HEART OUTPUT; HEMATOCRIT; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION RETINOPATHY; MALE; PLASMA VISCOSITY; VASCULAR RESISTANCE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VISCOSITY; DOXAZOSIN; FEMALE; FIBRINOGEN; HEMATOCRIT; HEMORHEOLOGY; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED;

EID: 0033501320     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. V. Annapurna, R.R. Puniyani and R.V. Gupte, Red cell deformability and erythrocyte lipids in hypertension, Clin. Hemorheol. 10 (1990), 95-101.
2. C. Carter, D. McGee, D. Reed, K. Yano and G. Stemmermann. Hematocrit and the risk of coronary heart disease: The Honolulu Heart Program, Am. Heart J. 105 (1983), 674-679.
3. S. Chien, Hemorheology in clinical medicine. Clin. Hemorheol. 2 (1982), 137-142.
4. R.B. Devereux, J.I.M. Drayer, S. Chien, T.G. Pickering, R.L. Letcher, J.L. DeYoung, J.E. Sealey and J.H. Laragh, Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension, Am. J. Cardiol. 54 (1984), 592-595.
5. L. Dintenfass, Viscosity factors in hypertensive and cardiovascular diseases, Cardiovasc. Med. 2 (1977), 337-353.
6. E. Ernst, Plasma fibrinogen - an independent cardiovascular risk factor, J. Int. Med. 227 (1990), 365-372.
7. E. Ernst and A. Matrai, Increased mortality in hypertensives treated with diuretics - a hemorheological problem?, Clin. Hemorheol. 4 (1984), 589-590.
8. E. Ernst, W. Koenig, A. Matrai and U. Keil, Plasma viscosity and hemoglobin in the presence of cardiovascular risk factors, Clin. Hemorheol. 8 (1988), 507-515.
9. B. Fulton, A.J. Wagstaff and E.M. Sorkin, Doxazosin - An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia, Drugs 49 (1995), 295-320.
10. S.S. Hayreh, G.E. Servais and P.S Virdi, Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy, Ophthalmology 93 (1986), 74-87.
11. N.K. Hollenberg, Hypertension: mechanisms and therapy, in: Ailas of Heart Diseases, Vol. 1, E. Braunwald, ed., Current Medicine, Philadelphia, 1995, pp. 13.15-13.16.
12. I. Horvath, B. Mezey, I. Juricskay, A. Simon and T. Javor, Data for the clinical evaluation of the impedance-cardiographic measurements, Card. Hung. (Hungarian) 22 (1993), 29-32.
13. W.B. Kannel, R.B, D'Agostino and A.J. Belanger, Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study, Am. Heart J. 113 (1987), 1006-1010.
14. W. Koenig, M. Sund, E. Ernst, A. Matrai, U. Keil and J. Rosenthal, Is increased plasma viscosity a risk factor for high blood pressure?, Angiology 40 (1989), 153-163.
15. W. Koenig, M. Sund, E. Ernst, U. Keil, J. Rosenthal and V. Hombach, Association between plasma viscosity and blood pressure. Results from the MONICA-project, Augsburg, Am. J. Hypertens. 4 (1991), 529-536.
16. W. Koenig, M. Sund, E. Ernst, R. Hehr, L. Binner, J. Rosenthal and V. Hombach, Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension - a randomized, double-bind, crossover study, J. Intern. Med. 229 (1991), 533-538.
17. W. Koenig, Recent progress in the clinical aspects of fibrinogen, Eur. Heart J. 16(Suppl. A) (1995), 54-59.
18. W.G. Kubicek, J.M. Karnegis, R.P. Patterson, D.A. Witsoe and R.H. Mattson, Development and evaluation of an impedance cardiac output system, Aerospace Med. 37 (1966), 1208-1212.
19. R. Leischman, The eye in general vascular disease: hypertension and arteriosclerosis, Br. J. Ophthalmol. 41 (1957), 641.
20. M. Leschke, M. Vogt, W. Motz and B.E. Strauer, Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension, Am. J. Cardiol. 65 (1990), 56G-59G.
21. E. Longhini, R. Agosti, P. Cherubini, A. Clivati, P. Fanni and L. Marazzini, Haemorheology in hypertension, Clin. Hemorheol. 6 (1986), 567-576.
22. G.D.O. Lowe, Evaluation of rheological therapy by orally administered drugs, Clin. Hemorheol. 4 (1984), 159-175.
23. G.D.O. Lowe, C.D. Forbes and W.S. Foulds, Haemorheology and retinal disorders, Clin. Hemorheol. 7 (1987), 181-188.
24. G.D.O. Lowe, W.C.S. Smith, H.D. Tunstall-Pedoe, I.K. Crombie, S.E. Lennie, J. Anderson and J.C. Barbenel, Cardiovascular risk and haemorheology - Results from the Scottish Heart Health Study and the MONICA project, Glasgow, Clin. Hemorheol. 8 (1988), 517-524.
25. M. Martinez, A. Vaya, M. Labios, F. Gabriel, V. Guiral and J. Aznar, The effect of long-term treatment with hypotensive drugs on blood viscosity and erythrocyte deformability in patients with essential arterial hypertension, Clin. Hemorheol. Microcirc. 17 (1997), 193-198.
26. A. Matrai, R.B. Whittington and E. Ernst, A simple method of estimating whole blood viscosity at standardized haematocrit, Clin. Hemorheol. 7 (1987), 261-265.
27. M. Peduzzi, A. Debbia, F. Guerrieri and R. Bolzani, Abnormal blood viscosity and filterability in retinal vein occlusion, Clin. Hemorheol. 4 (1984), 555-562.
28. S. Piermarocchi, T. Segato, H. Bertoja, E. Midena, M. Zucchetto, A. Girolami, M. Procidano and M. Mares, Branch retinal vein occlusion: The pathogenetic role of blood viscosity, Ann. Ophthalmol. 22 (1990), 303-311.
29. J.F. Stoltz, Cardiovascular diseases, risk factors and hemorheological parameters, Clin. Hemorheol. 3 (1981), 257-267.
30. P.M. Sweetnam, H.F. Thomas, J.W.G. Yamell, A.D. Beswick, I.A. Baker and P.C. Elwood, Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease: The Caerphilly and Speedwell Studies, Eur. Heart J. 17 (1996), 1814-1820.
31. B. Tsinamdzvrishvili, N. Beritashvili and G. Mchedlishvili, Further insight into blood rheological disturbances in essential hypertension, Clin. Hemorheol. 15 (1995), 697-705.
32. K. Toth, T. Habon, I. Horvath, B. Mezey, I. Juricskay and G.Y. Mozsik, Hemorheological and hemodynamical parameters in patients with ischemic heart disease at rest and at peak exercise, Clin. Hemorheol. 14 (1994), 329-338.
33. K. Toth, E. Ernst, T. Habon, I. Horvath, I. Juricskay and G.Y. Mozsik, Hemorheological and hemodynamical effects of fish oil (Ameu) in patients with ischemic heart disease and hyperlipoproteinemia, Clin. Hemorheol. 15 (1995), 867-875.
34. K. Toth, J. Nemes, L. Czopf, P. Kapronczay, G. Kesmarky and I. Juricskay, Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension, Clin. Hemorheol. Microcirc. 20 (1999), 57-61.
35. J. Vekasi, K. Toth, I. Juricskay and B. Kovacs, The role of hemorheological factors in hypertensive retinopathy, Clin. Hemorheol. 16 (1996), 187-192.
36. D.G. Waller, Whole blood viscosity following cardioselective beta-adrenoceptor blockade in hypertension, Clin. Hemorheol. 2 (1982), 243-247.
37. J.W. Yarnell, I.A. Baker, P.M. Sweetnam, D. Bainton, J.R. O-Brien, P.J. Whitehead and P.C. Elwood, Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies, Circulation 83 (1991), 836-844.